China's First Judicial Decision on Patent Linkage

The Beijing Intellectual Property Court recently issued the first-ever decision in a dispute between a brand-name and a generic drug company under China's newly-created patent linkage regime. Fang Qi and Danlei Wu of Fangda Partners examine the decision and its implications

12 minute readJune 09, 2022 at 11:38 PM
By
Fang Qi
& Danlei Wu
China's First Judicial Decision on Patent Linkage

Summary


  • China has recently introduced a patent linkage regime which aims to resolve patent disputes more quickly.
  • This regime was tested recently in a dispute between a brand-name and a generic drug company which was decided on by the Beijing IP Court.

A Subscription is Required to Access this Content

Subscribe to China Law & Practice today for:

  • ✓ A database of 3000+ essential documents, including key PRC laws translated into English
  • ✓ Newsletters with business-critical and sector-specific updates
  • ✓ Premium mobile access with timely analysis on China's fast-changing market

Already a Subscriber? Log In. Sign In Now

Questions? Contact us at [email protected] | 1-855-808-4530 (Americas) | 44(0) 800 098 386009 (UK & Europe)